YOU — what changed in the latest 10-Q
A section-by-section comparison of YOU's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-05 vs the prior 10-Q · 2026-05-06
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +25 | −10 | ~27 | 47 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~4 | 2 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +3 | −4 | 0 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-05
Total Bookings increased by $157.5 million, or 37%, for the six months ended June 30, 2026 compared to the six months ended June 30, 2025. The increase was primarily driven by growth in Active CLEAR+ Members as well as price increases.
expensed in the period incurred and certain overhead related expenses paid to the airports in relation to our Revenue Share arrangements.
30, 2025. Approximately 26% and 27%, respectively, of paying CLEAR+ Members were on a family plan as of June 30, 2026 and 2025, respectively.
Revenue increased by $99.9 million, or 23%, for the six months ended June 30, 2026 compared to the six months ended June 30, 2025. The change was primarily due to a 15% increase in the number of CLEAR+ Members as of June 30, 2026 compared to June 30, 2025 and increases to the price of a CLEAR+ membe…
Cost of revenue share fee increased by $8.1 million, or 26%, for the three months ended June 30, 2026 compared to the three months ended June 30, 2025. The change was driven primarily by an increase of $1.0 million, or a 9% increase, in fixed airport fees and $7.1 million, or a 34% increase, in per …
Text removed vs the prior filing · source: 10-Q · 2026-05-06
Cost of revenue share fee increased by $7.3 million, or 25%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. The change was driven primarily by an increase of $1.0 million, or an 11% increase, in fixed airport fees and $6.3 million, or a 31% increase, in …
Cost of direct salaries and benefits expenses decreased by $2.4 million, or 5%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. The change was primarily due to a decrease in employee compensation costs of $4.1 million caused by lower average employee coun…
Research and development expenses increased by $0.5 million, or 2%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. The change was primarily due to a $1.1 million increase in technology costs, partially offset by a $0.4 million decrease in professional fe…
Sales and marketing expenses increased by $2.6 million, or 19%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. The change was driven primarily by $1.9 million of higher commission expense primarily related to our B2B offering, CLEAR1, and $1.2 million of…
General and administrative expenses increased by $8.9 million, or 16%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. The change was driven by a $5.6 million increase in employee compensation costs primarily related to performance-based equity compensati…
Other information
Text added vs the prior filing · source: 10-Q · 2026-08-05
The adoption or termination of contracts, instructions or written plans for the purchase or sale of our securities by our Section 16 officers and directors for the three months ended June 30, 2026, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Ex…
Dennis LiuChief Accounting OfficerMay 14, 2026April 1, 202713,872
1Securities reported in this column reflect restricted stock units (“RSUs”) and shares of common stock, as appropriate. In the case of RSUs, quantities included in this column reflect the full amount of RSUs as reported in an officer’s respective plan and do not reflect the impact of tax withholding…
Text removed vs the prior filing · source: 10-Q · 2026-05-06
The adoption or termination of contracts, instructions or written plans for the purchase or sale of our
securities by our Section 16 officers and directors for the three months ended March 31, 2026, each of which is
intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (“Rule 10b5-1
*Securities reported in this column reflect restricted stock units (“RSUs”) and shares of common stock, as appropriate. In the case of RSUs, quantities included in this column reflect the full amount of RSUs as reported in an officer’s respective plan and do not reflect the impact of tax withholding…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice